These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 23063056)

  • 1. Collagen-induced thrombosis in murine arteries and veins.
    Cooley BC
    Thromb Res; 2013 Jan; 131(1):49-54. PubMed ID: 23063056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-modulatory effects of clopidogrel and heparin on platelet and fibrin incorporation in thrombosis.
    Cooley BC; Herrera AJ
    Blood Coagul Fibrinolysis; 2013 Sep; 24(6):593-8. PubMed ID: 23492917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen-induced thrombosis in large vessels using native prothrombotic substrates.
    Neeves KB
    Thromb Res; 2013 Jan; 131(1):1-2. PubMed ID: 23174625
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
    van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.
    Schulz C; Konrad I; Sauer S; Orschiedt L; Koellnberger M; Lorenz R; Walter U; Massberg S
    Thromb Haemost; 2008 Jan; 99(1):190-5. PubMed ID: 18217153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury.
    Hechler B; Gachet C
    Thromb Haemost; 2011 May; 105 Suppl 1():S3-12. PubMed ID: 21479341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions.
    Roald HE; Barstad RM; Kierulf P; Skjørten F; Dickinson JP; Kieffer G; Sakariassen KS
    Thromb Haemost; 1994 May; 71(5):655-62. PubMed ID: 8091395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
    Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
    J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein as a modulator of platelet and coagulation responses.
    van der Stoep M; Korporaal SJ; Van Eck M
    Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G; Casaní L; Badimon L
    Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
    Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
    FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals.
    Sturgeon SA; Jones C; Angus JA; Wright CE
    J Pharmacol Toxicol Methods; 2006; 53(1):20-9. PubMed ID: 16087355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.